Publications by authors named "Ivan Randelovic"

Claim this Profile
I
In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy.
Jacopo Gomena, Daniela Modena, Paola Cordella, Balázs Vári, Ivan Ranđelović

Eur J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer.
Laura Svajda, Ivan Ranđelović, Sára Eszter Surguta, Marcell Baranyi, Mihály Cserepes

Biomed Pharmacother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma.
Sára Eszter Surguta, Marcell Baranyi, Laura Svajda, Mihály Cserepes, Ivan Ranđelović

Sci Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas.
Nikolett Péczka, Ivan Ranđelović, Zoltán Orgován, Noémi Csorba, Attila Egyed

ACS Chem Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping protein binding sites by photoreactive fragment pharmacophores.
Péter Ábrányi-Balogh, Dávid Bajusz, Zoltán Orgován, Aaron B Keeley, László Petri

Commun Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade.
Enikő Tátrai, Ivan Ranđelović, Sára Eszter Surguta, József Tóvári

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.
Marcell Baranyi, Eszter Molnár, Luca Hegedűs, Zsófia Gábriel, Flóra Gréta Petényi

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate PhPCHCHSPh-κ,κ Ligand.
Gerd Ludwig, Ivan Ranđelović, Dušan Dimić, Teodora Komazec, Danijela Maksimović-Ivanić

Biomolecules· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Gábor Mező, Jacopo Gomena, Ivan Ranđelović, Endre Levente Dókus, Krisztina Kiss

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development.
Ivan Ranđelović, Kinga Nyíri, Gergely Koppány, Marcell Baranyi, József Tóvári

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH-Peptide Conjugates.
Ildikó Szabó, Beáta Biri-Kovács, Balázs Vári, Ivan Ranđelović, Diána Vári-Mező

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SREKA-targeted liposomes for highly metastatic breast cancer therapy.
Balázs Vári, Levente Dókus, Adina Borbély, Anikó Gaál, Diána Vári-Mező

Drug Deliv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Farnesyltransferase inhibitors have antitumoral effects in mutant KRAS containing cancer cells in preclinical models].
Marcell Baranyi, Balázs Hegedűs, Eszter Molnár, József Tóvári, Ivan Ranđelović

Magy Onkol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the enzymatic release of MMAE from DGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker.
Marco Zambra, Ivan Ranđelović, Francesco Talarico, Adina Borbély, Laura Svajda

Front Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covalent fragment mapping of KRas revealed novel chemotypes with in vivo potency.
Zoltán Orgován, Nikolett Péczka, László Petri, Péter Ábrányi-Balogh, Ivan Ranđelović

Eur J Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation-Free Sulfonyl Fluoride Probes for Fragment Screening.
László Petri, Péter Ábrányi-Balogh, Noémi Csorba, Aaron Keeley, József Simon

Molecules· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates.
Jacopo Gomena, Balázs Vári, Rita Oláh-Szabó, Beáta Biri-Kovács, Szilvia Bősze

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro anti-proliferative effect and in vivo antitumor action of daphnetin in different tumor cells.
F Alejandro Jiménez-Orozco, Ivan Ranđelović, Zita Hegedüs, Armando Vega-Lopez, Francisco Martínez-Flores

Cir Cir· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Application of Asn-Gly-Arg sequence based cyclic peptides for targeted tumor therapy].
Gábor Mező, Andrea Tripodi Angelo Pierluigi, Ivan Ranđelovič, Nóra Kata Enyedi, Beáta Biri-Kovács

Magy Onkol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of new fluorescent boro-β-carboline dyes.
Dénes Szepesi Kovács, Imre Hajdu, Gergely Mészáros, Lucia Wittner, Domokos Meszéna

RSC Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.
Andrea Angelo Pierluigi Tripodi, Ivan Ranđelović, Beáta Biri-Kovács, Bálint Szeder, Gábor Mező

Pathol Oncol Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer.
Levente E Dókus, Eszter Lajkó, Ivan Ranđelović, Diána Mező, Gitta Schlosser

Pharmaceutics· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Optimization of peptide-drug conjugates for targeted tumor therapy].
Gábor Mezõ, Beáta Biri-Kovács, Lilla Pethõ, Schuster Sabine, Krisztina Kiss

Magy Onkol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of therapeutic peptides targeting pancreatic cancer].
Gábor Mezõ, Levente Dókus, Gitta Schlosser, Eszter Lajkó, Zsófia Szász

Magy Onkol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium].
Kinga Nyíri, Gergely Koppány, Gyula Pálfy, István Vida, Szilárd Tóth

Magy Onkol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis